Secondary Sjögren syndrome (Q44391): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/953143133
@@ Property / Canonical URI: https://id.who.int/icd/entity/953143133 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:4A43.21
@@ Property / CURIE: CID11:4A43.21 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-4A43.21
@@ Property / Canary Token: dki-india-4A43.21 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+M35.0
@@ Property / Linked ICD 10: M35.0 / rank @@
+Normal rank

Latest revision as of 11:50, 13 August 2026

Secondary Sjögren syndrome is a progressive inflammatory autoimmune disease affecting the exocrine glands in the presence of other systemic autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis. Lymphocytic infiltrates replace functional epithelium, leading to oral and ocular dryness.

Language	Label	Description	Also known as
default for all languages	4A43.21
English	Secondary Sjögren syndrome	Secondary Sjögren syndrome is a progressive inflammatory autoimmune disease affecting the exocrine glands in the presence of other systemic autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis. Lymphocytic infiltrates replace functional epithelium, leading to oral and ocular dryness.